BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/16/2024 6:17:54 AM | Browse: 247 | Download: 1069
 |
Received |
|
2024-02-26 10:53 |
|
Peer-Review Started |
|
2024-02-26 10:53 |
|
First Decision by Editorial Office Director |
|
2024-04-29 20:51 |
|
Return for Revision |
|
2024-04-29 20:51 |
|
Revised |
|
2024-05-11 09:18 |
|
Publication Fee Transferred |
|
2024-06-10 04:03 |
|
Second Decision by Editor |
|
2024-06-06 02:48 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-06-06 08:56 |
|
Articles in Press |
|
2024-06-06 08:56 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-07-08 01:28 |
|
Publish the Manuscript Online |
|
2024-07-16 06:17 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cell Biology |
| Manuscript Type |
Basic Study |
| Article Title |
Parthenolide enhances the metronomic chemotherapy effect of cyclophosphamide in lung cancer by inhibiting the NF-kB signaling pathway
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zheng Cai, Lang Gao, Kai Hu and Qi-Ming Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Joint Funding of Yunnan Ministry of Science and Technology |
2019FF002-048 |
| Beijing Heathco Clinical Oncology Research Foundation |
Y-Q201802-048 |
|
| Corresponding Author |
Qi-Ming Wang, PhD, Doctor, Doctor, Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University, No. 127 Dong Ming Road, Zhengzhou 450008, Henan Province, China. qimingwang1006@126.com |
| Key Words |
Lung cancer; Parthenolide; Cyclophosphamide; Rhythmic chemotherapy; NF-κB pathway |
| Core Tip |
Our present study found that as a specific inhibitor of NF-kB, Parthenolide can promote the efficiency of cyclophosphamide in lung cancer via inhibiting NF-kB signaling in vitro and in vivo. Our present study will help scientists and clinicians to draw up novel rhythmic chemotherapy strategies. |
| Publish Date |
2024-07-16 06:17 |
| Citation |
Cai Z, Gao L, Hu K, Wang QM. Parthenolide enhances the metronomic chemotherapy effect of cyclophosphamide in lung cancer by inhibiting the NF-kB signaling pathway. World J Clin Oncol 2024; 15(7): 895-907 |
| URL |
https://www.wjgnet.com/2218-4333/full/v15/i7/895.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v15.i7.895 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
